MMCAP International Inc. SPC : Form 8.3 - Sandstorm Gold

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
114
MMCAP International Inc. SPC : Form 8.3 - Sandstorm Gold Ltd

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: MMCAP International Inc. SPC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):   The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:   Use a separate form for each offeror/offeree Sandstorm Gold Ltd
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken:   For an opening position disclosure, state the latest practicable date prior to the disclosure 01 June 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?   If it is a cash offer or possible cash offer, state "N/A" Mariana Resources Ltd  

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   Common Shares NPV
    Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:         (5,085,363) (3.35)
(2) Cash-settled derivatives:          
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:     (2,555,200) (1.68)
    TOTAL:           (7,640,563)   (5.03)
Class of relevant security:   Warrants 3.50 USD Expire 27 Oct 2020
    Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:   6,500,000   4.10    
(2) Cash-settled derivatives:          
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:          
    TOTAL:   6,500,000   4.10    
Class of relevant security:   Warrants 4.00 CAD Expire 03 Nov 2020
    Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:   856,722   0.56    
(2) Cash-settled derivatives:          
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:            
    TOTAL:   856,722   0.56      

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale   Number of securities Price per unit
  Common Shares NPV   Sold Short   1,500   4.5887 CAD

(b)        Cash-settled derivative transactions

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
           

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit
           

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
  NONE  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  NONE  

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 02 JUNE 2017
Contact name: ULLA VESTERGAARD
Telephone number: 001 416 408 0994

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC. Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1.         KEY INFORMATION

Full name of person making disclosure: MMCAP International Inc. SPC
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: Sandstorm Gold Ltd

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security Product description e.g. call option Written or purchased Number of securities to which option or derivative relates Exercise price per unit Type e.g. American, European etc. Expiry date
Common Shares NPV Call Option Written 50,000 3.00 USD American  19 Jan 2018
Common Shares NPV Call Option Written 1,414,100 4.00 USD American  19 Jan 2018
Common Shares NPV Call Option Written 48,000 5.00 USD American  19 Jan 2018
Common Shares NPV Call Option Written 47,200 7.00 USD American  19 Jan 2018
Common Shares NPV Call Option Written 25,000 4.00 USD American  18 Jan 2019
Common Shares NPV Call Option Written 869,900 5.00 USD American  18 Jan 2019
Common Shares NPV Call Option Written 50,000 4.00 USD American  16 Jun 2017
Common Shares NPV Call Option Written 1,000 5.00 USD American  16 Jun 2017
Common Shares NPV Put Option Written 50,000 3.00 USD American 15 Dec 2017

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:
   

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thrive Aviation Hires Bobby Perez for Charter Sales

Updated Category News Views 54

Bobby Perez Joins Thrive Aviation to Spearhead Charter Sales Private aviation isn't just about getting a ride anymore; it's the balance of luxury and logistic know-how. Enter Bobby Perez, the latest addition to Thrive Aviation's brain trust. With Thrive hanging its hat on being a top-tier name in private jets, snagging a veteran like Perez is the kind of move savvy...

Continue Reading
Lululemon Lawsuit Looms: Investors Face Key Decisions

Updated Category News Views 22

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

Continue Reading
First Move-Ins at Modera Ridgeline Begin Soon

Updated Category News Views 43

Mill Creek Sets Up Shop in McKinney You ever watch these neighborhoods sprout up like they’re out of nowhere? Seems like every time you blink, there’s another bunch of homes cropping up. Mill Creek Residential’s latest offering, Modera Ridgeline, joins the ranks with its 325 homes getting ready for squatters who prefer a bit of nature with their suburban sprawl....

Continue Reading
Azitra Reports Q3 2026: Key Developments in Biopharma Pipeline

Updated Category News Views 13

Unpacking Azitra's Recent Breakthroughs Azitra, Inc. galloped into the spotlight with their Q3 2026 financials and some hefty business updates. This isn’t just about dollars and cents; they've got some fascinating biotech news wrapped in. Riding High on ATR-COSF Ex Vivo Results All eyes are on Azitra’s ATR-COSF. The lab is lighting up with news — a 50% wrinkle...

Continue Reading
Genesis One Rolls Out Telehealth Wellness Platform

Updated Category News Views 15

Genesis One Enters the Fray with Home-Based Wellness In a health industry where everyone's screaming for transparency and flexibility, Genesis One is finding a sweet spot. They're throwing their hat in the ring with a new telehealth wellness pitch. Now, this isn't your everyday launch—it's a prelude to a January 2027 rollout, with co-founders Brent Messer and Dr. Alex...

Continue Reading
Flor de Caña's Green Strategy Wins 2026 Stevie Award

Updated Category News Views 30

Flor de Caña’s Environmental Triumph Seems like when folks think of premium rum, they might wanna start picturing not just smooth sips but a green commitment that runs deep. Flor de Caña has bagged a Stevie Award for their solid 'Net Zero Strategy of the Year.' This ain’t just any award; it's a nod from a respected crowd. A handshake from the business big shots who...

Continue Reading
Antengene's ATG-207 Breakthrough: Restoring Immune Balance

Updated Category News Views 19

Antengene's Ambitious Move in Autoimmune Diseases In a world where biotech buzzwords often outshine real data, Antengene's latest presentation at the 2026 American College of Rheumatology Annual Meeting packs a punch with its preclinical findings on ATG-207. This bifunctional fusion protein is paving the way for novel treatments targeting pesky T cell–mediated...

Continue Reading
Palestinian Doctor's Death Sparks Urgent Calls for Action

Updated Category News Views 54

When the world loses a healer like Dr. Rizk Abu Shaaira to an airstrike, it feels like we're spiraling further into a pit where humanity becomes collateral damage. Dr. Shaaira, a prominent Palestinian surgeon, found his life brutally cut short amid violence that's becoming as depressingly routine as my morning coffee—a routine nobody asked for. The Unforgiving Reality...

Continue Reading
Paytient Study Shows Cash Payments Shift Plans

Updated Category News Views 11

Healthcare Payment Preferences: A Deeper Look The Paytient-Greenwald study is rocking the boat, unveiling how insured folks opt to pay for healthcare cash and steer clear of claims. A Shift Towards Payability in Insurance We’re seeing something unusual with these findings—a staggering 61% of insured folks shelling out cash without ever filing a claim. Imagine paying...

Continue Reading
Natura's 3Q26 Performance: Navigating Bottlenecks and Potential

Updated Category News Views 61

Unexpected Performance Amidst Challenging Circumstances I'll tell you, navigating through operational bottlenecks is no small feat, but Natura seems to be brewing its own survival recipe. They reported a net income of BRL 49 million in the third quarter of 2026, clawing back from a net loss of BRL 119 million in the previous year. That's no magic trick; it's a reflection...

Continue Reading

Top 5 Most Recently Viewed Articles

Nipocalimab's Unique Design for IgG-Driven Diseases Explored

Updated Category News Views 254

Nipocalimab: A Breakthrough in Treating IgG-Driven Diseases Nipocalimab has emerged as a promising investigational treatment in the realm of IgG-driven alloantibody and autoantibody diseases. Recent results affirm its high-affinity binding characteristics and immunoselective properties. This groundbreaking monoclonal antibody has been shown to significantly reduce IgG...

Continue Reading
FTI Consulting Achieves Robust Earnings Despite Market Challenges

Updated Category News Views 64

FTI Consulting Reports Third Quarter Financial Results FTI Consulting, Inc. (NYSE: FCN) recently announced its financial performance for the third quarter, presenting a noteworthy achievement with earnings of $926 million, marking an increase compared to the previous year. This growth reflects the company's resilience and capacity to adapt amidst fluctuating market...

Continue Reading
FutureFuel Secures Key Approval for Clean Fuel Production

Updated Category News Views 331

FutureFuel Achieves Excise Tax Registration Approval FutureFuel Corp. (NYSE: FF), a leading player in the manufacturing of custom and performance chemicals and biofuels, has recently celebrated a significant success. The company has received its Excise Tax Registration approval from the Internal Revenue Service (IRS). This vital registration marks the first step towards...

Continue Reading
Natural Gas Services Group Increases 2024 EBITDA Guidance

Updated Category News Views 92

Natural Gas Services Group Announces Strong Q3 2024 Results Natural Gas Services Group, Inc. (NYSE: NGS), a prominent provider in the natural gas compression industry, has released its financial results for the third quarter ending September 30, 2024. The company reported significant growth in rental revenue, cash flow from operating activities, and net income, signifying...

Continue Reading
Apple's Leap Forward: C2 Modem Testing Signals 5G Advances

Updated Category News Views 331

Apple Inc. Enters a New Era with C2 Modem Testing Apple Inc. (NASDAQ: AAPL) is taking significant steps in advancing its connectivity technology by reportedly testing its second-generation C2 modem for the upcoming iPhone models. Latest Developments in Modem Technology Recently, a reliable source on X, previously known as Twitter, revealed that Apple is currently in the...

Continue Reading